Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 152 stories
17 October 2024 – 0 mins read
Financial results for the first nine months of 2024
The financial results for the first half of the year will be published on July 25, 2024 at 7H00 and a conference call will take place at 13H00 CET.
14 October 2024 – 2 mins read
Excellence in action: Ipsen is first pharma company to receive two Gold Shingo Prizes
Meeting the world’s highest standard for operational excellence is rare, and it’s even rarer to do it twice. Ipsen’s manufacturing site in Signes first received the Gold Shingo Prize for operational excellence in 2020.
11 October 2024 – 1 mins read
Sustainability in the Supply Chain: Ipsen’s First Supplier Sustainability Day
Sustainability plays a critical role in shaping the future of our business and the world at large. To ensure we embed sustainability in our supply chain, we recently hosted our inaugural Supplier Sustainability Day event, bringing in key partners to meet with Ipsen leaders.
04 October 2024 – 2 mins read
Looking after a loved one with Progressive Familial Intrahepatic Cholestasis: Francesca’s Story
A few months after Eva Luna was born, her mother Francesca realised something wasn’t quite right. Within the span of a few days, their world was turned upside down when her daughter was diagnosed with a rare liver disease, known as Progressive Familial Intrahepatic Cholestasis (PFIC). Yet despite th
01 October 2024 – 1 mins read
Ipsen Achieves Its Record-High Score in 2024 S&P Global CSA, Setting New Company Benchmark
We are proud to announce that Ipsen’s rating has reached an all-time high in the 2024 S&P Global Corporate Sustainability Assessment (CSA). Our score has increased by 4 points, from 57 in 2023 to 61 as od 19 September 2024, placing Ipsen in the 94th percentile of our industry. This remarkable achiev